Clinical trial
Facial Thermography Study of Levocetirizine Versus Cetirizine
NCT00150761 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00150761 |
|---|---|
| Title | Facial Thermography Study of Levocetirizine Versus Cetirizine |
| Official title | A Randomized, Double-blind, Double Dummy, Placebo Controlled, Cross-over Exploratory Trial in Healthy Male Adult Subjects: Comparison by Means of Infrared Thermography of the Anti-H1 Potency of Levocetirizine 5 mg and Cetirizine 10 mg Tablet Single Oral Dose After Nasal Histamine Provocation. |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anti-allergic Agents |
| Intervention type | Drug |
| Interventions | Levocetirizine (drug) |
| Enrollment | 60 |
| Start date | Jul 1, 2004 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Sep 8, 2005 |
| Last update posted | Aug 26, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: